Metabolic disorders

Citations 11-20 of 317 total displayed.

Education in Heart
Perioperative manipulation of the circulation in children with congenital heart disease

Lara Shekerdemian
Heart 2009; 95: 1286-1296. [Extract] [Full text] [PDF] [Request Permissions] [ Web only appendix ] BMJ Learning: Take this module on BMJ Learning  

Original articles
Effects of enzyme-replacement therapy in patients with Anderson–Fabry disease: a prospective long-term cardiac magnetic resonance imaging study

M Imbriaco, A Pisani, L Spinelli, A Cuocolo, G Messalli, E Capuano, M Marmo, R Liuzzi, B Visciano, B Cianciaruso, and M Salvatore
Heart 2009 95: 1103 -1107; published online before print as 10.1136/hrt.2008.162800 [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk

Jean-Pierre Després
Heart 2009; 95: 1118-1124. [Extract] [Full text] [PDF] [Request Permissions] [ Web only appendix ] BMJ Learning: Take this module on BMJ Learning  

Editorials
Is C-reactive protein a prognostic marker after angioplasty?

Dimitris Tousoulis, Nikos Papageorgiou, and Christodoulos Stefanadis
Heart 2009; 95: 957-959. [Extract] [Full text] [PDF] [Request Permissions]  

Original articles
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus

K M Goode, J John, A S Rigby, E S Kilpatrick, S L Atkin, T Bragadeesh, A L Clark, and J G F Cleland
Heart 2009 95: 917 -923; published online before print as 10.1136/hrt.2008.156646 [Abstract] [Full text] [PDF] [Request Permissions]  

Original articles
Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial

L G Mellbin, K Malmberg, A Waldenström, H Wedel, L Rydén, and for the DIGAMI 2 investigators
Heart 2009 95: 721 -727; published online before print as 10.1136/hrt.2008.152835 [Abstract] [Full text] [PDF] [Request Permissions]  

Original articles
Evolution and outcome of diastolic dysfunction

N Achong, S Wahi, and T H Marwick
Heart 2009 95: 813 -818; published online before print as 10.1136/hrt.2008.159020 [Abstract] [Full text] [PDF] [Request Permissions]  

Editorials
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do

Mark Sherlock, Andy A Toogood, and Richard Steeds
Heart 2009 95: 522 -523; published online before print as 10.1136/hrt.2008.163345 [Extract] [Full text] [PDF] [Request Permissions]  

Technology and guidelines
Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia

R Minhas, S E Humphries, N Qureshi, H A W Neil on behalf of the NICE Guideline Development Group
Heart 2009 95: 584 -587; published online before print as 10.1136/hrt.2008.162909 [Extract] [Full text] [PDF] [Request Permissions]  

Technology and guidelines
NICE guidance for identification and treatment of familial hypercholesterolaemia: Commentary 1

Tahseen A Chowdhury and Graham A Hitman
Heart 2009; 95: 587-589. [Extract] [Full text] [PDF] [Request Permissions]